MarketPulse

wound care

8 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

MediWound Eyes Q1 2026 Results as NexoBrid Gains Market Traction

MediWound to report Q1 2026 earnings May 27, updating investors on FDA-approved burn therapy NexoBrid and late-stage wound care candidate EscharEx.
MDWDfinancial resultsconference call
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Wound Cleanser Market to Double to $5.17B by 2035 on Tech Advances

Global wound cleanser market valued at $3.22B in 2025, projected to reach $5.17B by 2035 at 4.92% CAGR, driven by antimicrobial technology advances and rising chronic wounds.
JNJMMMSNNCLPBYmarket growthwound care
GlobeNewswire Inc.GlobeNewswire Inc.··Mordor Intelligence

Tissue Engineering Market Poised to Nearly Double to $27.6B by 2031

Tissue engineering market projected to grow from $15.01B to $27.59B by 2031 at 12.95% CAGR, driven by regenerative medicine advances and 3D bioprinting innovation.
MDTSNNZBHORGOIARTregenerative medicinebiomaterials
GlobeNewswire Inc.GlobeNewswire Inc.··Coloplast A/S

Coloplast Slashes Growth Outlook as Kerecis Struggles Post-Medicare Changes

Coloplast cuts FY 2025/26 guidance citing Kerecis underperformance following Medicare reimbursement changes, taking DKK 3B impairment charge.
CLPBYorganic growthwound care
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Sanuwave Health Posts Modest Q1 2026 Growth Amid Reimbursement Headwinds

Sanuwave Health reports Q1 2026 revenues of $9.6–$9.7M, up 3-4% YoY, citing reimbursement headwinds. CEO highlights strong Ultramist interest at SAWC conference.
SNWVregenerative medicinewound care
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Sanuwave Posts Record $44.1M Revenue on UltraMist Momentum, Eyes 16-25% Growth in 2026

Sanuwave Health reported record 2025 revenues of $44.1M, up 35% YoY, driven by strong UltraMist system sales and improved margins.
SNWVrevenue growthregenerative medicine
GlobeNewswire Inc.GlobeNewswire Inc.··Na

BioStem Technologies to Showcase Perinatal Tissue Platform at TD Cowen Healthcare Conference

BioStem Technologies will present its perinatal tissue-based wound care platform at the TD Cowen Healthcare Conference on March 2, 2026, in Boston.
BSEMregenerative medicinemedical devices
GlobeNewswire Inc.GlobeNewswire Inc.··Na

MiMedx to Present 2025 Full-Year Results and Fourth Quarter Performance on February 25

MiMedx will release 2025 financial results February 25, 2026, followed by a webcast and conference call at 4:30 p.m. ET with senior management.
MDXGfinancial resultsconference call